156 related articles for article (PubMed ID: 21362103)
1. An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis.
Malouf MA; Hopkins P; Snell G; Glanville AR;
Respirology; 2011 Jul; 16(5):776-83. PubMed ID: 21362103
[TBL] [Abstract][Full Text] [Related]
2. Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
Calvo E; Escudier B; Motzer RJ; Oudard S; Hutson TE; Porta C; Bracarda S; Grünwald V; Thompson JA; Ravaud A; Kim D; Panneerselvam A; Anak O; Figlin RA
Eur J Cancer; 2012 Feb; 48(3):333-9. PubMed ID: 22209391
[TBL] [Abstract][Full Text] [Related]
3. Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
Daniels CE; Lasky JA; Limper AH; Mieras K; Gabor E; Schroeder DR;
Am J Respir Crit Care Med; 2010 Mar; 181(6):604-10. PubMed ID: 20007927
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of the prognosis factors in patients with idiopathic pulmonary fibrosis].
Zhang J; Huang H; Lu ZW; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):174-8. PubMed ID: 21569682
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
[TBL] [Abstract][Full Text] [Related]
7. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study.
Bruyn GA; Tate G; Caeiro F; Maldonado-Cocco J; Westhovens R; Tannenbaum H; Bell M; Forre O; Bjorneboe O; Tak PP; Abeywickrama KH; Bernhardt P; van Riel PL;
Ann Rheum Dis; 2008 Aug; 67(8):1090-5. PubMed ID: 18037627
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis].
Wallaert B; Guetta A; Wemeau-Stervinou L; Tercé G; Valette M; Nevière R; Aguilaniu B
Rev Mal Respir; 2011 Mar; 28(3):290-6. PubMed ID: 21482330
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G; Schmidli H; Punch J; Tuttle-Newhall E; Mayer D; Neuhaus P; Samuel D; Nashan B; Klempnauer J; Langnas A; Calmus Y; Rogiers X; Abecassis M; Freeman R; Sloof M; Roberts J; Fischer L
Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777
[TBL] [Abstract][Full Text] [Related]
10. [Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].
Peng SC; Li ZH; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):260-3. PubMed ID: 18846961
[TBL] [Abstract][Full Text] [Related]
11. Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.
Motzer RJ; Escudier B; Oudard S; Hutson TE; Porta C; Bracarda S; Grünwald V; Thompson JA; Figlin RA; Hollaender N; Kay A; Ravaud A;
Cancer; 2010 Sep; 116(18):4256-65. PubMed ID: 20549832
[TBL] [Abstract][Full Text] [Related]
12. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
Alhamad EH; Masood M; Shaik SA; Arafah M
Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
[TBL] [Abstract][Full Text] [Related]
13. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
King TE; Brown KK; Raghu G; du Bois RM; Lynch DA; Martinez F; Valeyre D; Leconte I; Morganti A; Roux S; Behr J
Am J Respir Crit Care Med; 2011 Jul; 184(1):92-9. PubMed ID: 21474646
[TBL] [Abstract][Full Text] [Related]
14. Everolimus-related pulmonary toxicity in heart transplant recipients.
Expósito V; de Prada JA; Gómez-Román JJ; González-Vilchez F; Llano-Cardenal M; García-Camarero T; Fernández-Valls M; Ruano J; Martín-Durán R
J Heart Lung Transplant; 2008 Jul; 27(7):797-800. PubMed ID: 18582812
[TBL] [Abstract][Full Text] [Related]
15. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
16. Cough predicts prognosis in idiopathic pulmonary fibrosis.
Ryerson CJ; Abbritti M; Ley B; Elicker BM; Jones KD; Collard HR
Respirology; 2011 Aug; 16(6):969-75. PubMed ID: 21615619
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.
Budde K; Neumayer HH; Lehne G; Winkler M; Hauser IA; Lison A; Fritsche L; Soulillou JP; Fauchald P; Dantal J;
Nephrol Dial Transplant; 2004 Oct; 19(10):2606-14. PubMed ID: 15316094
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
Rothenburger M; Teerling E; Bruch C; Lehmkuhl H; Suwelack B; Bara C; Wichter T; Hinder F; Schmid C; Stypmann J
J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
[TBL] [Abstract][Full Text] [Related]
19. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.
Pereira CA; Malheiros T; Coletta EM; Ferreira RG; Rubin AS; Otta JS; Rocha NS
Respir Med; 2006 Feb; 100(2):340-7. PubMed ID: 16002271
[TBL] [Abstract][Full Text] [Related]
20. Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships.
Kovarik JM; Snell GI; Valentine V; Aris R; Chan CK; Schmidli H; Pirron U
J Heart Lung Transplant; 2006 Apr; 25(4):440-6. PubMed ID: 16563975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
